Man Group’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.62M Buy
121,545
+87,532
+257% +$1.17M ﹤0.01% 1284
2025
Q1
$347K Buy
+34,013
New +$347K ﹤0.01% 1677